Researchers based at University College London’s (UCL) Institute of Ophthalmology and Moorfields Eye Hospital, UK, have published research findings suggesting that the auto fluorescence (AF) pattern in Stargardt’s patients at baseline may influence the enlargement of atrophy over time and may additionally associate with particular genotypes. The findings, published in the journal Investigative Ophthalmology & Visual Science (2013; 54: 8181-8190. DOI: 10.1167/iovs.13-12104), suggest that the clinical results may be useful in the provision of patient counseling on disease prognosis and may also hold value in the design of future clinical trials of therapeutic agents to treat Stargardt’s disease.